Table 1 Baseline characteristics of breast cancer patients at time-of-diagnosis stratified by sex from CPRD GOLD.

From: Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021

 

Female

Male

Number of patients

85,400

507

Age in years (Median [IQR])

63 (52 to 73)

70 (61 to 78)

Age Groups in years N (%)

 18–29

278 (0.3%)

5 (1.0%)

 30–39

2860 (3.3%)

9 (1.8%)

 40–49

11,298 (13.2%)

29 (5.7%)

 50–59

21,496 (25.2%)

67 (13.2%)

 60–69

22,273 (26.1%)

129 (25.4%)

 70–79

15,090 (17.7%)

163 (32.1%)

 80–89

9665 (11.3%)

87 (17.2%)

 90+

2440 (2.9%)

18 (3.6%)

Prior history in the database (data availability), days

 Median [IQR]

3189 (1637—4992)

3337 (1763—4970)

Smoking status (any time 5 years prior)

 Non-smoker

41,286 (48.3%)

210 (41.4%)

 Former smoker

453 (0.5%)

 < 5

 Smoker

13,636 (16.0%)

73 (14.4%)

 Missing

30,025 (35.2%)

222 (43.8%)

General conditions (any time prior)

 Atrial fibrillation

2797 (3.3%)

51 (10.1%)

 Cerebrovascular disease

2676 (3.1%)

36 (7.1%)

 Chronic liver disease

216 (0.3%)

 < 5

 Chronic obstructive lung disease

2751 (3.2%)

38 (7.5%)

 Coronary arteriosclerosis

313 (0.4%)

 < 5

 Dementia

1082 (1.3%)

14 (2.8%)

 Depressive disorder

12,862 (15.1%)

53 (10.5%)

 Diabetes mellitus

5728 (6.7%)

63 (12.4%)

 Gastrointestinal haemorrhage

4403 (5.2%)

29 (5.7%)

 Heart failure

1380 (1.6%)

20 (3.9%)

 Hyperlipidemia

5865 (6.9%)

37 (7.3%)

 Hypertensive disorder

17,772 (20.8%)

142 (28.0%)

 Ischemic heart disease

3878 (4.5%)

62 (12.2%)

 Osteoarthritis

14,817 (17.4%)

92 (18.1%)

 Peripheral vascular disease

668 (0.8%)

12 (2.4%)

 Pulmonary embolism

582 (0.7%)

 < 5

 Renal impairment

6576 (7.7%)

57 (11.2%)

 Venous thrombosis

3485 (4.1%)

25 (4.9%)

  1. IQR: interquartile range.